ZTL 106
Alternative Names: ZTL-106Latest Information Update: 11 Mar 2022
At a glance
- Originator Zelira Therapeutics
- Class Analgesics; Anti-inflammatories; Anti-ischaemics; Muscle relaxants; Non-opioid analgesics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pain